Zuzana Diamant (Former)
81 – 99 of 99
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Role of T2 inflammation biomarkers in severe asthma.
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Obesity and asthma: current knowledge and future needs
(
- Contribution to journal › Scientific review
-
Mark
Antifungals in severe asthma
(
- Contribution to journal › Scientific review
-
Mark
Reproducibility of biomarkers in induced sputum and in serum from chronic smokers.
(
- Contribution to journal › Article
-
Mark
Guidance for the regulatory status of allergen extracts in clinical trials.
(
- Contribution to journal › Letter
-
Mark
Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen.
(
- Contribution to journal › Article
-
Mark
Application of nitric oxide measurements in clinical conditions beyond asthma.
(
- Contribution to journal › Article
-
Mark
Can a single dose response predict the effect of montelukast on exercise-induced bronchoconstriction?
2015) In Pediatric Pulmonology(
- Contribution to journal › Article
- 2014
-
Mark
The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice
(
- Contribution to journal › Scientific review
-
Mark
Current evidence and future research needs for FeNO measurement in respiratory diseases.
(
- Contribution to journal › Scientific review
-
Mark
Disease models of chronic inflammatory airway disease: applications and requirements for clinical trials.
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Launching the BIOSPIT initiative: Harmonizing sputum outcomes in multicenter trials
(
- Contribution to journal › Letter
-
Mark
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
(
- Contribution to journal › Article
-
Mark
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
(
- Contribution to journal › Article
-
Mark
Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: A survey
(
- Contribution to journal › Article
-
Mark
The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma
(
- Contribution to journal › Article
-
Mark
Which Biomarkers Are Effective for Identifying Th2-Driven Inflammation in Asthma?
(
- Contribution to journal › Scientific review
-
Mark
Inhaled allergen bronchoprovocation tests.
(
- Contribution to journal › Article
- 2012
-
Mark
Clinical aspects of using exhaled NO in asthma diagnosis and management
(
- Contribution to journal › Scientific review